Patent holdings for IPC class A61K 31/437

Total number of patents in this class: 10488

10-year publication summary

581
583
647
645
622
613
653
600
700
713
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Bristol-myers Squibb Company
4826
181
Incyte Corporation
1039
136
F. Hoffmann-La Roche AG
7937
134
Takeda Pharmaceutical Company Limited
2721
123
Genentech, Inc.
4016
122
Novartis AG
10612
109
Janssen Pharmaceutica N.V.
3358
106
Boehringer Ingelheim International GmbH
4636
100
Merck Sharp & Dohme LLC
3732
100
Gilead Sciences, Inc.
2106
95
Merck Patent GmbH
5752
85
The Regents of the University of California
20303
70
Hoffmann-La Roche Inc.
3546
69
Bayer Pharma AG
1048
69
Abbvie Inc.
1817
68
Dana-Farber Cancer Institute, Inc.
2626
67
Pfizer Inc.
3401
64
Plexxikon Inc.
148
59
Taisho Pharmaceutical Co., Ltd.
869
58
Galapagos NV
274
56
Other owners 8617